Haemonetics Q1 fiscal 2024 results announced; press release text not available

HAEMONETICS CORP

2024-Q1 EPS reported $0.80 revenue$311,332,000

Filing states Haemonetics issued a press release on Aug 8, 2023 for Q1 ended July 1, 2023.
No specific financial metrics (revenue, EPS, guidance) are provided in the extracted text.
Confidence low: cannot confirm actual performance numbers from this filing excerpt.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HAEMONETICS CORP reported financial results for the first quarter ended July 1, 2023.

Period: the first quarter ended July 1, 2023
Result: reported results

Exact text from the filing

On August 8, 2023, Haemonetics Corporation issued a press release announcing financial results for the first quarter ended July 1, 2023.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-23-000039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.